Fact CheckerSign in

NCT07598058Recruiting

PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry

Source: ClinicalTrials.gov · Last updated 26 Aug 2026

Brief summary (registry, in English)

The design is a prospective, observational registry for subjects with CHE under the care of dermatology or other qualified healthcare provider. Longitudinal data are collected from both subjects and their treating provider during routine clinical encounters using a structured and standardized data collection method

Status (registry)
Recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
13 May 2026
Start date
21 Jul 2026
Primary completion date
31 Dec 2099
Lead sponsor
CorEvitas
NCT number
NCT07598058

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 21 Jul 2026 to the primary completion date, 31 Dec 2099
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 1\) Is participating or planning to participate in a blinded clinical trial for a CHE drug

Other

  • An individual who meets any of the following criteria will be excluded from participation in the registry:

Who the study is looking for

  • To be eligible to participate in this registry, an individual must meet all of the following criteria:
    • Diagnosed with moderate-to-severe CHE by a dermatologist or other qualified healthcare provider at the time of enrollment and initiating an eligible medication.
    • Is at least 18 years of age or older and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted at the time of enrollment
    • Is willing and able to consent to participation in the registry
    • Is willing and able to complete registry-related forms electronically via personal devices.
    • Is willing and able to provide the information (first name, last name, email address, language and primary time zone) required to create an account to allow you to complete registry forms via a personal device;
    • Is willing and able to provide Personal Information (full legal name, sex, date of birth, home address zip or postal code and email address or phone number at a minimum) if required based on registry location and applicable laws and regulations.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CorEvitas, LLC
Coordinator of this site? Confirm its status
WalthamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.